PRTA - Prothena Biosciences Expected Profit

Official company branding of Prothena Corp (PRTA)

The financial stability of Prothena Corporation (PRTA) is constrained by intermittent partner payments and R&D expenditures. Anticipation of the Phase 3 trial results for AL amyloidosis will serve as the primary growth trigger. The organization's future profit trend helps assess its development vector, while 0.03 represents the latest level value. Prothena Corporation is scaling its neurobiology portfolio through strategic alliances with industry behemoths and the acquisition of innovative drug delivery platforms.

Prothena Corporation PLC (PRTA): Expected Net Profit from 08/29/2025 to 02/19/2026

Prothena Corporation - analytical breakdowns and key metrics (PRTA)

Fundamental company analysis:PRTA, Prothena Biosciences
Finished products of Prothena Biosciences

Projected earnings aggregate institutional expectations regarding future commercial returns, allowing investors to filter out market noise and assess the fundamental resilience of capital. By analyzing the trend of expected profitability, an investor can observe the balance between the development costs of neurodegenerative drugs at Prothena Corporation (PRTA) and the supporting payments from pharma partners, which confirms the stability of liquidity and the protection of the company's cash balance.

Competing companies

BIIB (Biogen) - Projected Future Earnings|Net Profit Forecast NBIX (Neurocrine Biosciences, Inc.)|Projected Future Earnings RGC|Axsome Corp - Net Profit Forecast|Projected Future Earnings ACAD (ACADIA Corp)|XENE: Net Profit Forecast|Viking Therapeutics Inc - Projected Future Earnings|Expected Net Profit Supernus Pharmaceuticals, Inc.|Catalyst Pharmaceuticals Inc (CPRX) - Expected Profit|DNLI (Denali Therapeutics Inc) - Expected Profit|Expected Profit Harmony Biosciences Holdings, Inc.|Expected Profit BHVN|Future Profit AMLX (Amylyx Pharmaceuticals, Inc.)|Future Net Profit TRVI|Expected Profit Praxis Precision Medicines, Inc. PRAX|Anavex Corp - Expected Profit|CBLL: Future Profit|Company Profit Forecast Alector ALEC|Annexon Inc. (ANNX) - Expected Profit|Omeros Corp. - Expected Net Income|NGNE (Neurogene Therapeutics) - Projected Future Earnings|Future Profit AC Immune Corp (ACIU)|Expected Profit Voyager Therapeutics (VYGR)|NMRA (Neumora Therapeutics) - Expected Net Income|Expected Profit Scilex Holding Co. SCLX|Expected Net Income TVGN|ACOG - Expected Profit|Expected Net Income CGTX (Cognition Therapeutics, Inc.)|IKT: Projected Future Earnings|Expected Net Profit cassavasciences.com (SAVA)|ASRT (Assertio Holdings, Inc.) - Projected Future Earnings|Future Profit coyatherapeutics.com (COYA)|Future Profit VTGN (vistagen.com)|Company Profit Forecast Ovid Rx|Projected Future Earnings ABOS (acumenpharm.com)|CRVO: Net Profit Forecast|Alterity Therapeutics Ltd. - Projected Future Earnings|Expected Net Profit clene.com|pepgen.com (PEPG) - Expected Profit|Expected Net Profit Jupiter Neurosciences, Inc. (JUNS)|Expected Profit Relmada Therapeutics|Net Profit Forecast ANVS (Annovis Bio, Inc.)|Projected Future Earnings GRCE|Company Profit Forecast Firefly Neuroscience, Inc.|Expected Profit anewmeds.com KLTO|Company Profit Forecast NeuroSense Therapeutics (NRSN)|RVPH: Future Profit|MTVA - Projected Future Earnings|NRXS (neuraxis.com) - Future Profit|Expected Net Profit Helius Medical Technologies Inc. (HSDT)|Expected Profit Passage Bio Corp|Future Profit Neuphoria Therapeutics (NEUP)|Projected Future Earnings NERV|ATHA - Expected Net Profit|Projected Future Earnings ADXN (addextherapeutics.com)|Alzamend (ALZN) - Expected Net Profit|CYCN: Future Profit|Expected Net Profit Protagenic Therapeutics Inc.|pasitheaclinics.com (KTTA) - Expected Profit|Expected Net Profit Cortigent Medical (CRGT)|ATXI (Avenue Therapeutics Inc) - Projected Future Earnings|BCLI (Brainstorm Cell Therapeutics Inc.) - Future Net Profit|Projected Future Earnings CARA|CHRO - Expected Net Profit|Eliem Therapeutics - Future Profit|Intra-Cellular (ITCI) - Expected Net Profit|LBPH - Expected Profit|MRNS - Projected Future Earnings|NKGN: Projected Future Earnings|NeuroBo Pharma (NRBO) - Projected Future Earnings|Future Profit SAGE|Net Profit Forecast SNPX (Synaptogenix, Inc.)|Expected Profit Trevena, Inc (TRVN)|VIGL (Vigil Neuroscience Inc.) - Expected Net Income|Expected Profit Anew Medical WENA|Future Net Profit CERE (Cerevel)